PAR-25-081-Full-Announcement.html

This document is a Notice of Funding Opportunity (NOFO) for the National Cancer Institute's (NCI) Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required) grant program.

The grant program seeks research projects that implement early phase (Phase 0, I, and II) investigator-initiated clinical trials focused on cancer-targeted diagnostic and therapeutic interventions. Eligible applicant types include county governments, higher education institutions, non-profit organizations, small businesses, and others. The proposed project must involve at least 1 clinical trial related to the scientific interests of NCI's research programs, such as the Cancer Therapy Evaluation Program and Cancer Imaging Program. The funding opportunity is associated with CFDA numbers 93.394 Cancer Detection and Diagnosis Research, 93.395 Cancer Treatment Research, 93.393 Cancer Cause and Prevention Research, and 93.399 Cancer Control. The grant is administered by the Department of Health and Human Services National Institutes of Health.